Health Professional Radio - Podcast

Returning guest, Dr. Brad Marder a nephrologist for nearly 20 years and now Medical Director of Nephrology at Horizon Therapeutics discusses findings from the Renal Data System study, on which he was an author, and how KRYSTEXXA (pegloticase) is applied in real-world care for people who receive dialysis for advanced kidney disease. These data were presented at the American Society of Nephrology (ASN) 2020, Abstract PO1166 titled "A USRDS Database Study on the Use of Pegloticase in Patients Undergoing Dialysis"